In chronic lymphocytic leukemia, microvesicles activate the AKT pathway and elevate the production of hypoxia-induced factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF), changing the bone marrow niche in a malignant direction [105]. The gene discussed is VEGFA; the disease is B-cell chronic lymphocytic leukemia.